The U.S. Food and Drug Administration has approved the first new treatment for gout in more than 40 years, a company saidSaturday.
Takeda Inc. said Uloric, a once-daily drug, was approved by the FDA on Friday to fight gout, a painful joint disease that mainly strikes middle-aged men. About 5 million people in the U.S. suffer from gout, a form of arthritis caused by a build-up of uric acid in theblood.
Uloric works by reducing levels of uricacid. Read the rest of this entry »
Recent research suggests that a diet high in meat, seafood and alcohol increases the risk of newly diagnosed gout. In addition, dairy products and coffee may be protective, lowering the risk of gout. However, these studies looked at people who had not had gout before. They did not assess the effect of diet on people who already had gout.
The list that you got of foods to avoid was probably a list of foods that are high in purines, a building block Read the rest of this entry »
SUNDAY, Oct. 26 (HealthDay News) — The drug pegloticase (Puricase) may help gout patients who’ve had no luck with other treatments, according to researchers who studied 212 patients who’d run out of treatment options.
They were randomly assigned to receive six months of intravenous treatment with either pegloticase or a placebo. One group of patients received 8 milligrams of pegloticase every two weeks, another group received 8 milligrams of pegloticase Read the rest of this entry »
Feb. 16, 2009 — The FDA has approved Uloric, the first new gout drug in
more than 40 years, according to Uloric’s maker, Takeda Pharmaceuticals.
Uloric, taken once daily by mouth, is approved for the chronic management of
hyperuricemia (elevated levels of uric acid) in gout patients.
Uloric works by blocking an enzyme called xanthine oxidase, which helps
prevent uric acid production, lowering elevated uric acid levels, according to
Takeda. Read the rest of this entry »
Seattle – Takeda Pharmaceuticals created Uloric to treat gout.
The FDA (Food and Drug Administration) approved this drug in 40 mg. and 80 mg. doses. Takeda requested approval in the 80 mg. and 120 mg. doses. However, the FDA denied this request, because they were concerned about potential cardiovascular side effects in the higher doses.
Takeda should take pride in the creation of Uloric, because it is the first treatment created for gout in over Read the rest of this entry »
US FDA has given approval to Uloric by Takeda Pharma for treatment of gout.
Patients of gout suffer from a painful condition with high levels of uric acid that can build up in the blood, joints and soft tissue.
According to Takeda, the Japanese drug maker, Uloric is the first new treatment option in more than four decades for gout. More than 5 million Americans are affected by the disease which causes inflammatory arthritis in men 40 and older. Read the rest of this entry »
The Food and Drug Administration accepted an application for
Savient Pharmaceuticals Inc.
’s gout drug pegloticase and will give the drug candidate a priority six-month review, Savient said Monday.
Savient said the FDA is aiming to complete its review of pegloticase by April 30, 2009. The intravenous drug is intended to treat cases of gout that have not responded to other therapies. The FDA accepted Savient’s biologics license application based Read the rest of this entry »
Q: I recently had my first experience with gout. I had bloodwork done, which showed high levels of uric acid. I was given a list of many foods I should avoid, but the list is so extensive. I’m not sure what to eat besides fruits and vegetables. What do you recommend to balance my diet? I would like to avoid taking medication unless I really need it.
I don’t recommend strict dietary modifications after an initial attack of gout. Here’s why.
Gout Read the rest of this entry »